Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honghua Jiang

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2009
Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetesWilliam H Herman, Kathleen M Dungan, Bruce H R Wolffenbuttel, et al.
European Journal of Medical Research|February 24, 2026
Effects of different early intervention strategies guided by GMOS, PDMS-2, or their combination on motor outcomes in preterm infants with PIVH: a randomized trialSuwei Ren, Ping Gan, Yanyan Cai, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 5, 2010
Impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens: a post hoc analysis of clinical trials in type 2 diabetes mellitusJaime A Davidson, Lyndon B Lacaya, Honghua Jiang, et al.
Animal Nutrition (Zhongguo Xu Mu Shou Yi Xue Hui)|November 4, 2022
Dietary <i>N</i>-carbamylglutamate and L-arginine supplementation improves redox status and suppresses apoptosis in the colon of intrauterine growth-retarded suckling lambsHao Zhang, Yi Zheng, Xia Zha, et al.
JAMA Network Open|February 8, 2023
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 StudyXue Hou, Meichen Li, Guowu Wu, et al.
The Lancet. Diabetes & Endocrinology|February 28, 2018
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trialBernhard Ludvik, Juan P Frías, Francisco J Tinahones, et al.
Blood|September 2, 2020
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndromeDavid C Dale, Frank Firkin, Audrey Anna Bolyard, et al.
Ophthalmology. Retina|June 4, 2026
Gildeuretinol Acetate vs Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The SAGA Randomized Clinical TrialDavid S Boyer, Leonide Saad, Ilyas Washington, et al.
Blood|April 21, 2024
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndromeRaffaele Badolato, Laia Alsina, Antoine Azar, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The Journal of Clinical Endocrinology and Metabolism|March 12, 2009
Racial and ethnic differences in mean plasma glucose, hemoglobin A1c, and 1,5-anhydroglucitol in over 2000 patients with type 2 diabetesWilliam H Herman, Kathleen M Dungan, Bruce H R Wolffenbuttel, et al.
European Journal of Medical Research|February 24, 2026
Effects of different early intervention strategies guided by GMOS, PDMS-2, or their combination on motor outcomes in preterm infants with PIVH: a randomized trialSuwei Ren, Ping Gan, Yanyan Cai, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 5, 2010
Impact of race/ethnicity on the efficacy and safety of commonly used insulin regimens: a post hoc analysis of clinical trials in type 2 diabetes mellitusJaime A Davidson, Lyndon B Lacaya, Honghua Jiang, et al.
Animal Nutrition (Zhongguo Xu Mu Shou Yi Xue Hui)|November 4, 2022
Dietary <i>N</i>-carbamylglutamate and L-arginine supplementation improves redox status and suppresses apoptosis in the colon of intrauterine growth-retarded suckling lambsHao Zhang, Yi Zheng, Xia Zha, et al.
JAMA Network Open|February 8, 2023
Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated EGFR-Mutant Non-Small Cell Lung Cancer in Patients With Brain Metastases: The GAP BRAIN Open-Label, Randomized, Multicenter, Phase 3 StudyXue Hou, Meichen Li, Guowu Wu, et al.
The Lancet. Diabetes & Endocrinology|February 28, 2018
Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trialBernhard Ludvik, Juan P Frías, Francisco J Tinahones, et al.
Blood|September 2, 2020
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndromeDavid C Dale, Frank Firkin, Audrey Anna Bolyard, et al.
Ophthalmology. Retina|June 4, 2026
Gildeuretinol Acetate vs Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The SAGA Randomized Clinical TrialDavid S Boyer, Leonide Saad, Ilyas Washington, et al.
Blood|April 21, 2024
A phase 3 randomized trial of mavorixafor, a CXCR4 antagonist, for WHIM syndromeRaffaele Badolato, Laia Alsina, Antoine Azar, et al.
Pageof 4